Icon Advisers Inc. Co. acquired a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,800 shares of the pharmacy operator’s stock, valued at approximately $304,000.
Other institutional investors and hedge funds have also modified their holdings of the company. CSat Investment Advisory L.P. raised its position in Walgreens Boots Alliance by 12.1% in the fourth quarter. CSat Investment Advisory L.P. now owns 1,920 shares of the pharmacy operator’s stock valued at $131,000 after purchasing an additional 208 shares during the period. Pathlight Investors LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter valued at $524,000. Roman Butler Fullerton & Co. raised its position in Walgreens Boots Alliance by 28.8% in the first quarter. Roman Butler Fullerton & Co. now owns 22,127 shares of the pharmacy operator’s stock valued at $1,400,000 after purchasing an additional 4,942 shares during the period. James Investment Research Inc. purchased a new stake in Walgreens Boots Alliance in the fourth quarter valued at $963,000. Finally, Tiemann Investment Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 2.7% in the 4th quarter. Tiemann Investment Advisors LLC now owns 22,190 shares of the pharmacy operator’s stock valued at $1,516,000 after buying an additional 586 shares during the period. 61.62% of the stock is currently owned by institutional investors.
WBA traded down $0.56 on Wednesday, hitting $51.13. 3,543,707 shares of the company traded hands, compared to its average volume of 6,457,458. The company has a quick ratio of 0.38, a current ratio of 0.78 and a debt-to-equity ratio of 0.50. The company has a market cap of $47.33 billion, a PE ratio of 8.49, a P/E/G ratio of 1.05 and a beta of 0.77. Walgreens Boots Alliance Inc has a 12-month low of $50.79 and a 12-month high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). The company had revenue of $34.53 billion for the quarter, compared to analysts’ expectations of $34.57 billion. Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.73 earnings per share. As a group, sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Monday, May 20th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.
In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the sale, the chief accounting officer now owns 435,811 shares in the company, valued at approximately $23,119,773.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Ornella Barra purchased 18,000 shares of the stock in a transaction that occurred on Wednesday, April 3rd. The stock was purchased at an average price of $54.56 per share, for a total transaction of $982,080.00. Following the acquisition, the chief operating officer now owns 26,425 shares in the company, valued at $1,441,748. The disclosure for this purchase can be found here. Corporate insiders own 15.73% of the company’s stock.
Several research analysts recently commented on WBA shares. Loop Capital lowered their target price on Walgreens Boots Alliance to $77.00 and set a “buy” rating for the company in a research note on Wednesday, March 27th. They noted that the move was a valuation call. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Friday, March 29th. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $77.00 to $67.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 5th. Barclays lowered their target price on Walgreens Boots Alliance from $78.00 to $60.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 3rd. Finally, Mizuho set a $67.00 target price on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Thursday, March 28th. Five equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $67.89.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
See Also: Bollinger Bands
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.